-
Date Time 11:00 - 12:00
Location Webinar Timezone America/New York
Overview
Centers for Medicare & Medicaid Services (CMS) will begin negotiating with manufacturers on the price of Medicare Part D drugs beginning this year. In September, CMS will publish the list of 10 Part D selected drugs for negotiations. A key issue in the negotiations will be determination of the fair market price for a product.
ICON panelists will bring their perspectives on critical issues around support for a product’s fair market price.
Key discussion topics
- Outline how CMS might select the 10 products that will be required to negotiate their prices this fall
- Describe how CMS will determine fair market prices for Medicare Part D drugs
- Suggest actions that manufacturers could take in response to the Medicare Part D price negotiation requirements
Moderator:
![](https://icon.widen.net/content/2c343d28-ea1f-42d7-bf13-4e65eb4a8b51/web/McCoy-Mark-New.png?crop=yes&w=240&h=240&itok=CJ2UzKzQ)
Mark McCoy
Director Client Engagement, ICON Pricing, Market Access & Reimbursement
ICON panelists:
![](https://icon.widen.net/content/a170add8-7802-46ea-90db-e62d9f7defd3/web/Biggs_Earlene_10_-(1).png?crop=yes&w=240&h=240&itok=RzYLVZbo)
Earlene Biggs
Divisional Principal, Market Access
![](https://icon.widen.net/content/c992f048-b9e6-4b83-80c2-8f766e0086ec/web/Capobianco_Bruce.png?crop=yes&w=240&h=240&itok=g5JfJNki)
Bruce Capobianco
Senior Director, Real World Evidence
![](https://icon.widen.net/content/2386d58e-275e-42c0-90ee-42aada7d9985/web/Obradovic-Tanja.png?crop=yes&w=240&h=240&itok=f2WqPPcP)
Tanja Obradovic
VP, Scientific Affairs, Oncology Medical Strategy
![](https://icon.widen.net/content/b31de2fb-5692-4212-a64e-0d454ee20f45/web/Park_Ki.png?crop=yes&w=240&h=240&itok=IXFjP3Hb)
Ki Park
VP Patient Insight, Market Access & Commercial
![](https://icon.widen.net/content/0ecd0d38-b8fd-4bd9-b837-044b9560097f/web/Risebrough_Nancy.png?crop=yes&w=240&h=240&itok=RCIFiKGl)
Nancy Risebrough
Senior Principal, Global HEOR
Audience
This webinar will benefit pharmaceutical and biotech professionals in the following areas:
- Channel Marketing
- Clinical
- Competitive Intelligence
- Government Affairs
- Health Economics and Outcomes Research
- Market Access
- Marketing
- Managed Markets
- Market Research
- Real World Evidence
- Regulatory Affairs